Qiagen borrows from US for $730m CB
Qiagen, a dutch biotechnology services firm, raised $730m through a dual tranche convertible bond on Wednesday morning, re-opening the equity-linked market after a lull during the results period.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts